Associat Professor of Pathology, Sungkyunkwan University School of Medicine, Samsung Medical center

Speciality Interests

Breast pathology

Schedule

schedule of week
06 MON
16
TUE
17
WEN
18
THU
19
FRI
20
AM
PM

Medical School

Seoul National University College of Medicine

Specialty Training

Specialty Training
Fellowship   Asan Medical Center
Kangbuk Samsung Hospital
Residency   Samsung Medical Center
Internship   Seoul National University Hospital

Participation in Academic Societies
and Research

  • · A member of Korean Pathology Society
    · A member of Korean Breast Cancer Society
    · A member of Korean Cytopathology Society

Thesis

  • CANCER RES TREAT 2024 10.4143/crt.2024.092 A Nationwide Study on HER2-Low Breast Cancer in South Korea: Its Incidence of 2022 Real World Data and the Importance of Immunohistochemical Staining Protocols Kim, MC; Cho, EY; Park, SY; Lee, HJ; Lee, JS; Kim, JY; Lee, HC; Yoo, JY; Kim, HS; Kim, B; Kim, WS; Shin, N; Maeng, YH; Kim, HS; Kwon, SY; Kim, C; Jun, SY; Kwon, GY; Choi, HJ; Lee, SM; Choi, JE; An, AR; Choi, HJ; Kim, E; Kim, A; Kim, JY; Shim, JY; Gong, GYY; Bae, YK
    View PubMed
  • ANTICANCER RES 2024 10.21873/anticanres.17227 Real-world Comparison of P53 Immunohistochemistry and TP53 Mutation Analysis Using Next-generation Sequencing Lee, H; Cho, YA; Kim, DG; Son, JY; Cho, EY
    View PubMed
  • J BREAST CANCER 2024 10.4048/jbc.2024.0065 Prediction of Oncotype DX Recurrence Score Based on Systematic Evaluation of Ki-67 Scores in Hormone Receptor- Positive Early Breast Cancer Kim, JM; Cho, EY
    View PubMed
  • HUM PATHOL 2024 10.1016/j.humpath.2024.02.002 Residual pure intralymphatic carcinoma component only (lymphovascular tumor emboli without invasive carcinoma) after neoadjuvant chemotherapy is associated with poor outcome: Not pathologic complete response Lee, H; Jang, Y; Cho, YA; Cho, EY
    View PubMed
  • CANCER RES TREAT 2024 10.4143/crt.2023.800 Next-Generation Sequencing in Breast Cancer Patients: Real-World Data for Precision Medicine Lee, H; Cho, YA; Kim, DG; Cho, EY
    View PubMed
  • INT J MOL SCI 2023 10.3390/ijms242115576 A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Jung, HH; Kim, JY; Cho, EY; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH
    View PubMed
  • EXP MOL MED 2023 10.1038/s12276-023-01030-z Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer Kim, JY; Park, S; Cho, EY; Lee, JE; Jung, HH; Chae, BJ; Kim, SW; Nam, SJ; Cho, SY; Park, YH; Ahn, JS; Lee, S; Im, YH
    View PubMed
  • FRONT ONCOL 2023 10.3389/fonc.2023.1146934 Lymphocyte-activating gene 3 expression in tumor cells predicts immune checkpoint inhibitor response in triple negative breast cancer Kim, JY; Kim, J; Cho, EY; Park, YH; Ahn, JS; Kim, KM; Im, YH
    View PubMed
  • VIRCHOWS ARCH 2022 10.1007/s00428-022-03280-0 Histologic analysis according to HER2 gene status in HER2 2+invasive breast cancer: a study of 280 cases comparing ASCO/CAP 2013 and 2018 guideline recommendations Hwang, HW; Hong, SA; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY
    View PubMed
  • NPJ BREAST CANCER 2022 10.1038/s41523-021-00364-z Ductal carcinoma in situ: a risk prediction model for the underestimation of invasive breast cancer Park, KW; Kim, SW; Han, H; Park, M; Han, BK; Ko, EY; Choi, JS; Cho, EY; Cho, SY; Ko, ES
    View PubMed
  • CANCERS 2021 10.3390/cancers13215260 Elevated Level of Nerve Growth Factor (NGF) in Serum-Derived Exosomes Predicts Poor Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy Jung, HH; Kim, JY; Cho, EY; Oh, JM; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-96855-x Deep learning from HE slides predicts the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancer patients Cho, SY; Lee, JH; Ryu, JM; Lee, JE; Cho, EY; Ahn, CH; Paeng, K; Yoo, I; Ock, CY; Song, SY
    View PubMed
  • BREAST CANCER RES TR 2021 10.1007/s10549-021-06310-8 Prediction of pathologic complete response to neoadjuvant chemotherapy using machine learning models in patients with breast cancer Kim, JY; Jeon, E; Kwon, S; Jung, H; Joo, S; Park, Y; Lee, SK; Lee, JE; Nam, SJ; Cho, EY; Park, YH; Ahn, JS; Im, YH
    View PubMed
  • CANCERS 2021 10.3390/cancers13040739

    Metformin Reduces Histone H3K4me3 at the Promoter Regions of Positive Cell Cycle Regulatory Genes in Lung Cancer Cells

    Kim1, D; Kim, Y; Lee, BB; Cho, EY; Han, J; Shim, YM; Kim, DH

    ASIA-PAC J CLIN ONCO 2020 10.1111/ajco.13444

    Distribution of tumor subtypes in bilateral breast cancer Comparison between synchronous and metachronous cancer

    Kim1, H; Lee, H; Choi, DH; Park, W; Cho, WK; Nam, SJ; Lee, JE; Kim, SW; Lee, SK; Cho, EY; Cho, SY

    J CLIN MED 2020 10.3390/jcm9103067

    Negative Effect of Reduced NME1 Expression on Recurrence-Free Survival in Early Stage Non-Small Cell Lung Cancer

    Kim1, D; Kim, Y; Lee, BB; Kim, D; Lee, OJ; Jeong, P; Kim, WJ; Cho, EY; Han, J; Shim, YM; Kim, DH

    BREAST CANCER RES TR 2020 10.1007/s10549-020-05874-1

    Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancer

    Kim1, JY; Jung, HH; Sohn, I; Woo, SY; Cho, H; Cho, EY; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH

    DIAGN PATHOL 2020 10.1186/s13000-020-00995-z

    Accuracy and efficiency of an artificial intelligence tool when counting breast mitoses

    Pantanowitz1, L; Hartman, D; Qi, Y; Cho, EY; Suh, B; Paeng, K; Dhir, R; Michelow, P; Hazelhurst, S; Song, SY; Cho, SY

    ANTICANCER RES 2020 10.21873/anticanres.14271

    Primary Peritoneal High-grade Serous Carcinoma Misinterpreted as Metastatic Breast Carcinoma: A Rare Encounter in Peritoneal Fluid Cytology

    Park1, S; Cho, EY; Oh, YL; Park, YH; Kim, HS

    BREAST CANCER RES TR 2019 10.1007/s10549-019-05192-1

    miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway

    Lee1, J; Kim, HE; Song, YS; Cho, EY; Lee, A

    J BREAST CANC 2019 10.4048/jbc.2019.22.e17

    Human Epidermal Growth Factor Receptor 2-positive Mucinous Carcinoma with Signet Ring Cell Differentiation, Which Showed Complete Response after Neoadjuvant Chemotherapy

    Jang1, Y; Cho, EY; Cho, SY

    J CELL MOL MED 2019 10.1111/jcmm.14194

    Metformin and tenovin-6 synergistically induces apoptosis through LKB1-independent SIRT1 down-regulation in non- small cell lung cancer cells

    Lee1, BB; Kim, Y; Kim, D; Cho, EY; Han, J; Kim, HK; Shim, YM; Kim, DH

    PLoS One 2019 10.1371/journal.pone.0212309

    Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment

    Kwon1, AY; Park, HY; Hyeon, J; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY

    BREAST CANCER RES TR 2019 10.1007/s10549-018-4981-x

    A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients

    Hwang1, HW; Jung, H; Hyeon, J; Park, YH; Ahn, JS; Im, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Choi, M; Cho, SY; Cho, EY

    ANTICANCER RES 2019 10.21873/anticanres.13121

    Clinicopathological and Molecular Characteristics of Mammary Adenoid Cystic Carcinoma With Adipocytic Differentiation With Emphasis on the Identification of a Novel BRAF Mutation

    Bae1, GE; Yoon, N; Cho, EY; Kim, HS; Cho, SY

    J BREAST CANC 2018 10.4048/jbc.2018.21.e48

    PIK3CA Mutations and Neoadjuvant Therapy Outcome in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Sequential Analysis

    Seo1, Y; Park, YH; Ahn, JS; Im, YH; Nam, SJ; Cho, SY; Cho, EY

    BREAST CANCER RES TR 2018 10.1007/s10549-018-4858-z

    Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort

    Kim1, JY; Lim, JE; Jung, HH; Cho, SY; Cho, EY; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH

    EXP MOL PATHOL 2018 10.1016/j.yexmp.2018.03.006

    Shallow whole genome sequencing for robust copy number profiling of formalin-fixed paraffin-embedded breast cancers

    Chin1, SF; Santonja, A; Grzelak, M; Ahn, S; Sammut, SJ; Clifford, H; Rueda, OM; Pugh, M; Goldgraben, MA; Bardwell, HA; Cho, EY; Provenzano, E; Rojo, F; Alba, E; Caldas, C

    Ultrasound Q 2017 10.1097/RUQ.0000000000000307

    Lymphoma Involving Skin and Subcutaneous Fat of the Breast: Two Cases

    Kwon1, M; Ko, EY; Han, BK; Ko, YH; Cho, EY; Cho, SY; Kim, SY

    J BREAST CANC 2017 10.4048/jbc.2017.20.3.286

    NanoString nCounter (R) Approach in Breast Cancer: A Comparative Analysis with Quantitative Real-Time Polymerase Chain Reaction, In Situ Hybridization, and Immunohistochemistry

    Hyeon1, J; Cho, SY; Hong, ME; Kang, SY; Doe, I; Im, YH; Cho, EY

    ASIA-PAC J CLIN ONCO 2017 10.1111/ajco.12652

    Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy

    Kim1, H; Park, W; Huh, SJ; Choi, DH; Noh, JM; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Cho, EY

    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10(2):1738-1746

    Tumor-associated macrophages (TAMs) and tumor-infiltrating lymphocytes (TILs) in pretherapeutic breast cancer core biopsies: Anti-tumoral effect of immune cells associated with neoadjuvant chemotherapy

    Yoon N1, Han KM, Cho SY, Kim SW, Lee JE, Nam SJ, Cho EY

    Genet Med. 2016 Dec;18(12):1250-1257. doi: 10.1038/gim.2016.39. Epub 2016 Apr 28.

    Comparative analysis of BRCA1 and BRCA2 variants of uncertain significance in patients with breast cancer: a multifactorial probability-based model versus ACMG standards and guidelines for interpreting sequence variants

    Park KS11, Cho EY2, Nam SJ3, Ki CS4, Kim JW4.

    Breast Cancer Res Treat. 2016 Dec;160(3):475-489. doi: 10.1007/s10549-016-4008-4. Epub 2016 Oct 11.

    Assessment of pathologic response and long-term outcome in locally advanced breast cancers after neoadjuvant chemotherapy: comparison of pathologic classification systems

    Choi M11, Park YH2, Ahn JS2, Im YH2, Nam SJ3, Cho SY4, Cho EY5.

    J Thorac Oncol. 2016 Dec;11(12):2193-2201. doi: 10.1016/j.jtho.2016.07.021. Epub 2016 Aug 4.

    Overexpression of beta-Catenin and Cyclin D1 is Associated with Poor Overall Survival in Patients with Stage IA-IIA Squamous Cell Lung Cancer Irrespective of Adjuvant Chemotherapy

    Kim Y11, Jin D1, Lee BB1, Cho EY2, Han J2, Shim YM3, Kim HK3, Kim DH4.

    Cancer Res Treat. 2016 Oct;48(4):1338-1350. Epub 2016 Feb 18.

    Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer

    Kim JY11, Park K2, Jung HH3, Lee E2, Cho EY4, Lee KH5, Bae SY6, Lee SK6, Kim SW6, Lee JE6, Nam SJ6, Ahn JS1, Im YH1,3, Park YH1,3.

    Medicine (Baltimore). 2016 Jan;95(3):e2453. doi: 10.1097/MD.0000000000002453.

    Assessment of Invasive Breast Cancer Heterogeneity Using Whole-Tumor Magnetic Resonance Imaging Texture Analysis Correlations With Detailed Pathological Findings

    Ko ES11, Kim JH, Lim Y, Han BK, Cho EY, Nam SJ.

    J Breast Cancer. 2016 Sep;19(3):330-333. Epub 2016 Sep 23.

    Radiologic Findings of Primary Mucinous Cystadenocarcinoma of the Breast: A Report of Two Cases and a Literature Review

    Seong M11, Ko EY1, Han BK1, Cho SY2, Cho EY2, Lee SK3, Lee JE3.

    Sci Rep. 2016 Jun 24;6:28623. doi: 10.1038/srep28623.

    Gene Expression Profiling of Breast Cancer Brain Metastasis

    Lee JY11, Park K2, Lee E2, Ahn T2, Jung HH3, Lim SH1, Hong M4, Do IG4, Cho EY4, Kim DH5, Kim JY1, Ahn JS1, Im YH1,2, Park YH1,3.

    Genes Chromosomes Cancer. 2016 Jun;55(6):495-504. doi: 10.1002/gcc.22351. Epub 2016 Mar 3.

    Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade

    Yoon N11, Bae GE2, Kang SY1, Choi MS1, Hwang HW1, Kim SW3, Lee JE3, Nam SJ3, Gong G4, Lee HJ4, Bae YK5, Lee A6, Cho EY1.

    Clin Breast Cancer. 2016 Jun;16(3):e15-21. doi: 10.1016/j.clbc.2015.11.008. Epub 2015 Dec 11.

    Limited Supraclavicular Radiation Field in Breast Cancer With >= 10 Positive Axillary Lymph Nodes

    Yu JI11, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.

    Acta Radiol. 2016 May;57(5):521-8. doi: 10.1177/0284185115590287. Epub 2015 Jun 12.

    Shear-wave elastography in invasive ductal carcinoma: correlation between quantitative maximum elasticity value and detailed pathological findings

    Cho EY11, Ko ES2, Han BK3, Kim RB4, Cho S1, Choi JS3, Hahn SY3.

    Int J Exp Pathol. 2016 Apr;97(2):170-7. doi: 10.1111/iep.12187. Epub 2016 Jun 9.

    Expression of FOXM1 and related proteins in breast cancer molecular subtypes

    Lee JJ11, Lee HJ2, Son BH3, Kim SB4, Ahn JH4, Ahn SD5, Cho EY6, Gong G2.

    Clin Breast Cancer. 2015 Dec;15(6):512-8. doi: 10.1016/j.clbc.2015.06.004. Epub 2015 Jun 18.

    Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments

    Yu JI11, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.

    PLoS One. 2015 Dec 2;10(12):e0144046. doi: 10.1371/journal.pone.0144046. eCollection 2015.

    Initial Experience with a Wireless Ultrasound-Guided Vacuum-Assisted Breast Biopsy Device

    Choi ER11, Han BK1, Ko ES1, Ko EY1, Choi JS1, Cho EY2, Nam SJ3.

    Clin Breast Cancer. 2015 Oct;15(5):353-61.e1-2. doi: 10.1016/j.clbc.2015.01.008. Epub 2015 Feb 7.

    Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06)

    Yu JI11, Choi DH2, Huh SJ1, Cho EY3, Kim K4, Chie EK4, Ha SW4, Park IA5, Ahn SJ6, Lee JS7, Shin KH8, Kwon Y8, Kim YB9, Suh CO9, Koo JS10, Kim JH11, Jeong BG12, Kim IA13, Lee JH14, Park W1.

    Int J Cancer. 2015 Apr 15;136(8):1976-84. doi: 10.1002/ijc.29233. Epub 2014 Dec 24.

    A seven-gene signature can predict distant recurrence in patients with triple- negative breast cancers who receive adjuvant chemotherapy following surgery

    Park YH11, Jung HH, Do IG, Cho EY, Sohn I, Jung SH, Kil WH, Kim SW, Lee JE, Nam SJ, Ahn JS, Im YH.

    Radiology. 2015 Apr;275(1):235-44. doi: 10.1148/radiol.14141129. Epub 2014 Dec 11.

    Volume-based Metabolic Tumor Response to Neoadjuvant Chemotherapy Is Associated with an Increased Risk of Recurrence in Breast Cancer

    Hyun SH11, Ahn HK, Park YH, Im YH, Kil WH, Lee JE, Nam SJ, Cho EY, Choi JY.

    Clin Epigenetics. 2015 Mar 19;7(1):32. doi: 10.1186/s13148-015-0066-4. eCollection 2015.

    RAR beta 2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung

    Kim Y11, Jin D1, Lee BB1, Cho EY2, Han J2, Shim YM3, Kim DH4.

    Oncology. 2014;86(5-6):279-88. doi: 10.1159/000362281. Epub 2014 Jun 4.

    Validation and Comparison of CS-IHC4 Scores with a Nomogram to Predict Recurrence in Hormone Receptor-Positive Breast Cancers

    Park YH11, Im SA, Cho EY, Ahn JH, Woo SY, Kim S, Keam B, Lee JE, Han W, Nam SJ, Park IA, Noh DY, Yang JH, Ahn JS, Im YH.

    Radiology. 2014 Apr;271(1):30-7. doi: 10.1148/radiol.13131073. Epub 2013 Nov 21.

    Apparent Diffusion Coefficient in Estrogen Receptor-Positive Invasive Ductal Breast Carcinoma: Correlations with Tumor-Stroma Ratio

    Ko ES11, Han BK, Kim RB, Cho EY, Ahn S, Nam SJ, Ko EY, Shin JH, Hahn SY.

    J Breast Cancer. 2014 Mar;17(1):83-7. doi: 10.4048/jbc.2014.17.1.83. Epub 2014 Mar 28.

    Polyostotic Fibrous Dysplasia Mimicking Multiple Bone Metastases in a Patient with Ductal Carcinoma In Situ

    Lee JH11, Kim SY2, Lee JE1, Cho EY3, Choi YL3, Choi JY4, Han SW2, Kim SW1, Kil WH1, Nam SJ1.

    Hum Pathol. 2014 Dec;45(12):2480-7. doi: 10.1016/j.humpath.2014.08.015. Epub 2014 Sep 7.

    Invasive Paget disease of the breast: 20 years of experience at a single institution

    Lee HW11, Kim TE1, Cho SY1, Kim SW2, Kil WH2, Lee JE2, Nam SJ2, Cho EY3.

    Korean J Radiol. 2014 Jan-Feb;15(1):20-8. doi: 10.3348/kjr.2014.15.1.20. Epub 2014 Jan 8.

    Breast Metastases from Extramammary Malignancies: Typical and Atypical Ultrasound Features

    Mun SH11, Ko EY2, Han BK2, Shin JH2, Kim SJ3, Cho EY4.

    APMIS. 2014 Sep;122(9):755-60. doi: 10.1111/apm.12215. Epub 2013 Dec 20.

    Analysis of HER2 status in breast carcinoma by fully automated HER2 fluorescence in situ hybridization (FISH): comparison of two immunohistochemical tests and manual FISH

    Yoon N11, Do IG, Cho EY.

    Tumour Biol. 2014 Jul;35(7):7079-84. doi: 10.1007/s13277-014-1952-7. Epub 2014 Apr 24.

    Aberrant DNA methylation of integrin alpha 4 in human breast cancer

    Do SI11, Ko E, Kang SY, Lee JE, Nam SJ, Cho EY, Kim DH.

    J Breast Cancer. 2014 Jun;17(2):113-20. doi: 10.4048/jbc.2014.17.2.113. Epub 2014 Jun 27.

    Positive Expression of Insulin-Like Growth Factor-1 Receptor Is Associated with a Positive Hormone Receptor Status and a Favorable Prognosis in Breast Cancer

    Shin SJ11, Gong G1, Lee HJ1, Kang J2, Bae YK3, Lee A4, Cho EY5, Lee JS6, Suh KS7, Lee DW8, Jung WH9.

    Mod Pathol. 2013 May;26(5):677-84. doi: 10.1038/modpathol.2012.205. Epub 2012 Dec 14.

    Heterogeneity of ERBB2 in gastric carcinomas: a study of tissue microarray and matched primary and metastatic carcinomas

    Cho EY11, Park K, Do I, Cho J, Kim J, Lee J, Kim S, Kim KM, Sohn TS, Kang WK, Kim S.

    Korean J Pathol. 2013 Apr;47(2):172-6. doi: 10.4132/KoreanJPathol.2013.47.2.172. Epub 2013 Apr 24.

    Congenital Peribronchial Myofibroblastic Tumor: A Case Study and Literature Review

    Kim Y11, Park HY, Cho J, Han J, Cho EY.

    Ann Surg Oncol. 2013 Mar;20(3):1005-12. doi: 10.1245/s10434-012-2727-2. Epub 2012 Nov 1.

    Synergistic Effect of Bcl-2 and Cyclin A2 on Adverse Recurrence-Free Survival in Stage I Non-small Cell Lung Cancer

    Ko E11, Kim Y, Cho EY, Han J, Shim YM, Park J, Kim DH.

    Clin Cancer Res. 2013 Mar 1;19(5):1204-12. doi: 10.1158/1078-0432.CCR-12-2848. Epub 2013 Jan 14.

    Association of RASSF1A and p63 with Poor Recurrence-Free Survival in Node-Negative Stage I-II Non-Small Cell Lung Cancer

    Ko E11, Lee BB, Kim Y, Lee EJ, Cho EY, Han J, Shim YM, Park J, Kim DH.

    Tumour Biol. 2013 Feb;34(1):445-53. doi: 10.1007/s13277-012-0569-y. Epub 2012 Nov 14.

    Expression of TWIST1, Snail, Slug, and NF-kappa B and methylation of the TWIST1 promoter in mammary phyllodes tumor

    Do SI11, Kim JY, Kang SY, Lee JJ, Lee JE, Nam SJ, Cho EY.

    Acta Oncol. 2013 Jan;52(1):73-81. doi: 10.3109/0284186X.2012.731520. Epub 2012 Oct 17.

    Prognostic impact of FOXP3 expression in triple-negative breast cancer

    Lee S11, Cho EY, Park YH, Ahn JS, Im YH.

    J Breast Cancer. 2012 Dec;15(4):381-7. doi: 10.4048/jbc.2012.15.4.381. Epub 2012 Dec 31.

    HER2 Status by Standardized Immunohistochemistry and Silver-Enhanced In Situ Hybridization in Korean Breast Cancer

    Bae YK11, Gong G, Kang J, Lee A, Cho EY, Lee JS, Suh KS, Lee DW, Jung WH; Breast Pathology Study Group of Korean Society of Pathologists.

    Am J Surg Pathol. 2012 Dec;36(12):1817-25. doi: 10.1097/PAS.0b013e318267b012.

    Hormone Receptor Expression in Invasive Breast Cancer Among Korean Women and Comparison of 3 Antiestrogen Receptor Antibodies A Multi-institutional Retrospective Study Using Tissue Microarrays

    Bae YK11, Gong G, Kang J, Lee A, Cho EY, Lee JS, Suh KS, Lee DW.

    Korean J Pathol. 2012 Dec;46(6):554-61. doi: 10.4132/KoreanJPathol.2012.46.6.554. Epub 2012 Dec 26.

    Methylation and Immunoexpression of p16(INK4a) Tumor Suppressor Gene in Primary Breast Cancer Tissue and Their Quantitative p16(INK4a) Hypermethylation in Plasma by Real-Time PCR

    Lee JJ11, Ko E, Cho J, Park HY, Lee JE, Nam SJ, Kim DH, Cho EY.

    Tumour Biol. 2012 Oct;33(5):1573-80. doi: 10.1007/s13277-012-0411-6. Epub 2012 May 13.

    The prognostic significance of tumor-associated stroma in invasive breast carcinoma

    Ahn S11, Cho J, Sung J, Lee JE, Nam SJ, Kim KM, Cho EY.

    Lung Cancer. 2012 Aug;77(2):401-6. doi: 10.1016/j.lungcan.2012.03.027. Epub 2012 Apr 24.

    Reduced expression of cyclin D2 is associated with poor recurrence-free survival independent of cyclin D1 in stage III non-small cell lung cancer

    Ko E11, Kim Y, Park SE, Cho EY, Han J, Shim YM, Park J, Kim DH.

    Invest Radiol. 2012 Jun;47(6):368-75. doi: 10.1097/RLI.0b013e31824baff3.

    Hepatic Fat Quantification A Prospective Comparison of Magnetic Resonance Spectroscopy and Analysis Methods for Chemical-Shift Gradient Echo Magnetic Resonance Imaging With Histologic Assessment as the Reference Standard

    Kang BK11, Yu ES, Lee SS, Lee Y, Kim N, Sirlin CB, Cho EY, Yeom SK, Byun JH, Park SH, Lee MG.

    Pathology. 2012 Apr;44(3):216-20. doi: 10.1097/PAT.0b013e3283513e8b.

    Comparison of four immunohistochemical tests and FISH for measuring Her2 expression in gastric carcinomas

    Cho EY11, Srivastava A, Park K, Kim J, Lee MH, Do I, Lee J, Kim KM, Sohn TS, Kang WK, Kim S.

    Cancer?Chemother Pharmacol.?2011 Sep;68(3):753-61. doi: 10.1007/s00280-010-1548-x. Epub 2010 Dec 18.

    Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)

    Cho EY11,?Chang MH,?Choi YL,?Lee JE,?Nam SJ,?Yang JH,?Park YH,?Ahn JS,?Im YH.

    Comparative Study of Metaplastic Breast Carcinoma and Triple-Negative Breast Carcinoma Using Histologic and Immunohistochemical Analyses

    Breast Cancer Res. 2010;12(6):R100. doi: 10.1186/bcr2783. Epub 2010 Nov 23.

    Cystatin M loss is associated with the losses of estrogen receptor, progesterone receptor, and HER4 in invasive breast cancer

    Ko E11, Park SE, Cho EY, Kim Y, Hwang JA, Lee YS, Nam SJ, Bang S, Park J, Kim DH.

    J Surg Oncol. 2010 Sep 1;102(3):225-9. doi: 10.1002/jso.21607.

    The Prediction of Lymph Node Metastasis in Ductal Carcinoma In Situ With Microinvasion by Assessing Lymphangiogenesis

    Lee SK11, Cho EY, Kim WW, Kim SH, Hur SM, Kim S, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.

    Cancer Res. 2010 Jul 15;70(14):5674-8. doi: 10.1158/0008-5472.CAN-08-2660. Epub 2010 Jun 15.

    PIK3CA Mutations in In situ and Invasive Breast Carcinomas

    Miron A11, Varadi M, Carrasco D, Li H, Luongo L, Kim HJ, Park SY, Cho EY, Lewis G, Kehoe S, Iglehart JD, Dillon D, Allred DC, Macconaill L, Gelman R, Polyak K.

    No items found.

    Intracystic Papillary Carcinoma in the Male Breast

    J Surg Oncol. 2010 Feb 1;101(2):137-40. doi: 10.1002/jso.21453.

    Characteristics of Metastasis in the Breast From Extramammary Malignancies

    Lee SK11, Kim WW, Kim SH, Hur SM, Kim S, Choi JH, Cho EY, Han SY, Hahn BK, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.

    No items found.

    Increased Expression of Autophagy Protein Beclin1 and LC3 in High-grade Hepatocellular Carcinoma and Metastatic Carcinoma

    J Korean Med Sci. 2008 Dec;23(6):1053-61. doi: 10.3346/jkms.2008.23.6.1053. Epub 2008 Dec 24.

    Comparison of Her-2, EGFR and Cyclin D1 in Primary Breast Cancer and Paired Metastatic Lymph Nodes: An Immunohistochemical and Chromogenic In Situ Hybridization Study

    Cho EY11, Han JJ, Choi YL, Kim KM, Oh YL.

    Int J Cancer. 2008 Nov 1;123(9):2073-9. doi: 10.1002/ijc.23598.

    CpG island hypermethylation of E-cadherin (CDH1) and integrin alpha 4 is associated with recurrence of early stage esophageal squamous cell carcinoma

    Lee EJ11, Lee BB, Han J, Cho EY, Shim YM, Park J, Kim DH.

    J Korean Med Sci. 2008 Apr;23(2):185-92. doi: 10.3346/jkms.2008.23.2.185.

    The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: Incidence of disease entities by age groups

    Cho EY11, Kim KH, Kim WS, Yoo KH, Koo HH, Ko YH.

    Pathol Int. 2008 Jan;58(1):17-25.

    Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: Immunohistochemistry and chromogenic in situ hybridization

    Cho EY11, Choi YL, Han JJ, Kim KM, Oh YL.

    AJNR Am J Neuroradiol. 2007 Aug;28(7):1242-8.

    Spinal epidural hemangiomas: Various types of MR imaging features with histopathologic correlation

    Lee JW11, Cho EY, Hong SH, Chung HW, Kim JH, Chang KH, Choi JY, Yeom JS, Kang HS.

    APMIS. 2007 Jun;115(6):713-8.

    AMACR is highly expressed in gastric adenomas and intestinal-type carcinomas

    Cho EY11, Kim KM, Park CK, Kim JJ, Sohn TS, Kim DW.

    Cytopathology. 2007 Feb;18(1):20-7.

    Fine needle aspiration cytology of solitary fibrous tumours of the pleura

    Cho EY11, Han JJ, Han J, Oh YL.

    J Korean Med Sci. 2006 Jun;21(3):425-9.

    Polycystin-1 expression in fetal, adult and autosomal dominant polycystic kidney

    Chae SW11, Cho EY, Park MS, Lee KB, Kim H, Kim U.

    Eur J Cancer. 2006 May;42(7):972-80. Epub 2006 Mar 27.

    Aberrant methylation of Fragile Histidine Triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinoma

    Lee EJ11, Lee BB, Kim JW, Shim YM, Hoseok I, Han J, Cho EY, Park J, Kim DH.

    Int J Gynecol Cancer. 2006 May-Jun;16(3):1000-6.

    Relationship between p53-associated proteins and estrogen receptor status in ovarian serous neoplasms

    Cho EY11, Choi YL, Chae SW, Sohn JH, Ahn GH.

    Radiology. 2006 Apr;239(1):105-12. Epub 2006 Feb 16.

    Macrovesicular hepatic steatosis in living liver donors: Use of CT for quantitative and qualitative assessment

    Park SH11, Kim PN, Kim KW, Lee SW, Yoon SE, Park SW, Ha HK, Lee MG, Hwang S, Lee SG, Yu ES, Cho EY.

    Pathol Int. 2006 Feb;56(2):62-70.

    Immunohistochemical study of the expression of adhesion molecules in ovarian serous neoplasms

    Cho EY11, Choi Y, Chae SW, Sohn JH, Ahn GH.

    Hum Pathol. 2002 Jul;33(7):732-40.

    Focal follicular features in tonsillar diffuse large B-cell lymphomas: Follicular lymphoma with diffuse areas or follicular colonization

    Ree HJ11, Kikuchi M, Lee SS, Ohshima K, Yang WI, Ko YH, Cho EY, Rhee JC.

    J Korean Med Sci. 2002 Feb;17(1):137-40.

    Trilateral retinoblastoma: A case report

    Cho EY11, Suh YL, Shin HJ.

    Hum Pathol. 2001 Sep;32(9):954-62.

    Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: Significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma

    Ree HJ11, Yang WI, Kim CW, Huh J, Lee SS, Cho EY, Ko YH, Charney D.

    Appl Immunohistochem Mol Morphol. 2001 Sep;9(3):222-8.

    Immunoexpression of inhibin alpha-subunit in adrenal neoplasms

    Cho EY11, Ahn GH.

    Acta Cytol. 2001 May-Jun;45(3):353-9.

    Fine needle aspiration cytology of sclerosing adenosis of the breast

    Cho EY11, Oh YL.

    CLOSE

    Patients' Rights and Responsibilities

    Patients' Rights

    1. Right to receive medical care

    Patients have the right to receive proper care in a safe setting without discrimination nor should their right to care be violated regardless of their gender, age, religion, social status, nationality, language, race, or physical/mental/financial status. Medical teams shall not refuse to provide care without justifiable reason.

    2. Right to be informed and to make an autonomous decision

    Patients have the right to obtain full and complete information from their medical team, to ask questions, and to determine their agreement or refusal concerning: diagnosis, treatment (purpose, plans and methods), outcomes of care (including unanticipated outcomes), discharge plan, participation in medical research studies, organ transplantation/donation, etc. Within ethical boundaries, patients may discontinue or refuse treatment, request that the medical team explain and suggest alternative treatments, and reserve the right to make their own decisions.

    3. Right to confidentiality

    Patients' rights to confidentiality regarding their physical/health status and privacy will not be violated. Patients can expect that all medical records/reports and their personal privacy will be kept confidential unless the patient has given consent or disclosure is permitted by law. To ensure their privacy, patients may be informed that Individuals not directly involved in their care may not be present and that the number of guardians accompanying patients to consultation rooms may be limited.

    4. Right to request consultation and mediation

    In the event of a medical dispute, patients may request consultation and mediation from an internal or external agency (Korea Consumer Agency, Korea Medical Dispute Mediation and Arbitration Agency).

    5. Right to have values and beliefs respected

    Patients will not be discriminated against because of their culture, religious values, or beliefs, and their rights will not be violated.

    6. Right to receive care in a safe setting

    Patients have the right to receive hospital-provided care where the patient’s medical information is protected and patient safety can be assured. In addition, patients have the right to be protected from possible dangers that can occur in a hospital and to have stability of mind and body.

    Patients' Responsibilities

    1. Responsibility to trust and respect the medical team

    Patients must accurately inform the medical team of their health condition and must trust and respect the medical team's treatment plan. Patients may be responsible for consequences that result from not following instructions.

    2. Responsibility to not use dishonest methods for medical treatment

    Patients must reveal their identity before receiving any medical care and must not use false or dishonest methods, such as seeking medical care under disguised ownership.

    3. Responsibility to abide by all hospital regulations

    Patients are expected to treat all hospital staff and other patients with courtesy and respect; to abide by all hospital rules; and to earnestly fulfill their financial obligation to the hospital. Also, patients and their family members are expected to participate in all safety regulations.